Clark WR, Mueller B, Kraus A, et al. 1997. Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Neph, 8:804–12. Cole L, Bellomo R, Hart G, et al. 2002. A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med, 30:100–6. Conger JD. 1995. Interventions in clinical acute renal failure: what are the data? Am J Kidney Dis, 26:565. Davenport A, Will E, Davidson A. 1993. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med, 21: 328–38. Davenport A, Will EJ, Davison AM. 1994. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump driven extracorporeal circuits in patient with combined acute renal and hepatic failure. Nephron, 66:431–7. Favre H, Martin PY, Stoermann C. 1996. Anticoagulation in continuous extracorporeal renal replacement therapy. Semin Dial, 9:112–18. Flanigan MJ, Von Brecht JH, Freeman RM, et al. 1987. Reducing the hemorrhagic complications of dialysis: a controlled comparison of low dose heparin and citrate anticoagulation. Am J Kid Dis, 9: 147–51. Gillum DM, Kelleher SP, Dillingham MA, et al. 1986. The role of intensive dialysis in acute renal failure. Clin Nephrol, 25:249. Golper TA, Leone M. 1989. Back transport of dialysate during in vitro continuous arteriovenous hemodialysis. Blood Purif, 7:223. Gotch FA, Sargent JA. 1985. A mechanistic analysis of the National Cooperative Dialysis Study. (NCDS). Kidney Int, 28:526–34. Grootendorst AF, Van Bommel EFH, Van Der Hoven B, et al. 1992. High- volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Car, 7:67–75. Held PJ, Port FK, Turenne MN, et al. 1994. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int, 45:1163–9. Honore PM, Jamez J, Wauthier M, et al. 2000. Prospective evaluation of short-term, high-volume isovolumic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med, 28:3581–7. Hory B, Cachoux A, Toulemonde F. 1985. Continuous arteriovenous hemofiltration with low-molecular-weight heparin. Nephron, 42:125. Kelber J, Delmez JA, Windus DW. 1993. Factors affecting delivery of high-efficiency dialysis using temporary vascular access. Am J Kidney Dis, 22:24–9. Kellum JA, Angus DC, Johnson JP, et al. 2002. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med, 28:29–37. Kellum JA, Mehta RL, Angus DC, et al. 2002. The first international consensus conference on continuous renal replacement therapy. Kidney Int, 62:1855–63. Kihara M, Ikeda Y, Shibata K, et al. 1994. Slow hemodialysis performed during the day in managing renal failure in critically ill patients. Nephron, 67:36–41. Kutsogiannis DJ, Mayers I, Chin WD, et al. 2000. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis, 35:802–11. Levraut J, Ciebiera JP, Jambou P. et al. 1997. Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med, 25:58–62. Levy EM, Visconti CM, Horwitz RI. 1996. The effect of renal failure on mortality: a cohort analysis. JAMA, 1489–94. Lewis J, Chertow GM, Paginini E, et al. 1997. A multi-center survey of patient characteristics, practice patterns, and outcomes in critically ill patients with ARF. J Am Soc Nephrol, 8:A0673. Macias WA, Clark WR. 1996. Acid base balance in continuous renal replacement therapy. Semin Dial, 9:145–51. Renal replacement therapy Mann B, Doig CJ, Lee H, et al. 2003. Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery. Crit Care Med, 31:449–55. McDonald BR, Mehta RL. 1990. Transmembrane flux of IL-1B and TNF- in patients undergoing continuous arteriovenous hemodialysis (CAVHD). J Am Soc Nephrol, 1:368. Mehta RL, Clark WC, Schetz M. 2002. Techniques for assessing and achieving fluid balance in acute renal failure. Curr Opin Crit Care, 8:535–43. Mehta RL, Dobos GJ, Ward DM. 1992. Anticoagulation in continuous renal replacement procedures. Semin Dial, 5:61–8. Mehta RL, Letteri JM. 1999. Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. Am J Nephrol, 19:377–82. Mehta RL, McDonald BR, Aguilar MM. 1990. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int, 38:976–81. Mehta RL, Mcdonald B, Gabbai F, et al. 1996. Continuous vs intermittent hemodialysis for acute renal failure in the ICU: results from a randomized multicenter trial. J Am Soc Nephrol, 5:1457. Mendelssohn DC, Hyman A. 2002. Current Canadian approaches to dialysis for acute renal failure in the ICU. Am J Nephrol, 22:29–34. Metnitz PG, Krenn CG, Steltzer H, et al. 2002. Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med, 30:2051–8. Murphy SW, Foley RN, Barrett BJ, et al. 2000. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney Int, 57: 1720–6. Paganini E, O’Hara P, Nakamoto S. 1984. Slow continuous ultrafiltration in hemodialysis resistant oliguric renal failure. Trans Am Soc Artif Intern Organs, 30:173–8. Palevsky PM. 1996. Continuous renal replacement therapy component selection: replacement fluid and dialysate. Semin Dial, 9:107–11. Palevsky PM, Burr R, Moreland L, et al. 1995. Failure of low molecular weight dextran to prevent clotting during continuous renal replacement therapy. ASAIO J, 24:847–9. Phu NH, Hien TT, Mai NT, et al. 2002. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Eng J Med, 347:895–902. Ronco C, Bellomo R, Homel P, et al. 2000. Effects of different doses in continuous veno-venous hemodialysis on outcomes of acute renal failure: a prospective randomized trial. Lancet, 355:26–30. Schetz M. 1999. Non-renal indications for continuous renal replacement therapy. Kidney Int Suppl, 72:S88–94. Schiffl H, Lang SM, Fischer R. 2002. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med, 346:305–10. Schrader J, Stibbe W, Kandt M, et al. 1990. Low molecular weight heparin versus standard heparin. A long-term study in hemodialysis and hemofiltration patients. ASAIO Trans, 36:28–32. Schwab SJ, Onorato JJ, Sharar LR, et al. 1987. Hemodialysis without anticoagulation. One-year prospective trial in hospitalized patients at risk for bleeding. Am J Med, 83:405. Siegler MH, Teehan BP. 1987. Solute transport in continuous hemodialysis: a new treatment for acute renal failure. Kidney Int, 32:562–71. Silvester W. 1997. Mediator removal with CRRT: complement and cytokines. Am J Kidney Dis, 30(5 Suppl 4):S38–43. Silvester W, Bellomo R, Cole L. 2001. Epidemiology, management, and outcome of severe acute renal failure of critical illness in Australia. Crit Care Med, 29:1910–15. Stalter KA, Stevens GF, Sterling WA Jr. 1986. Late stenosis of the subclavian vein after hemodialysis catheter injury. Surgery, 100: 924–7. Therapeutics and Clinical Risk Management 2005:1(2) 149